Illumina Fails To Shred Syntrix DNA Patent After $96M Verdict

Law360, New York (May 3, 2013, 6:12 PM EDT) -- A Washington federal judge on Friday affirmed the validity of a Syntrix Biosystems Inc. patent covering DNA technology that a jury previously found was infringed by competitor Illumina Inc. as part of a $96 million verdict, ruling a claim construction in Syntrix's patent was "sufficiently clear".

U.S. District Judge Benjamin H. Settle rejected Illumina's bid to have Syntrix's patent invalidated on grounds that the patent term “known discrete full thickness volume” was indefinite. Even though there may be some disagreement among people in the field, the...
To view the full article, register now.